نتایج جستجو برای: mtd

تعداد نتایج: 1531  

Journal: :Journal of neurosurgery 2015
Gentian Kaloshi Ermir Roci Arben Rroji Francois Ducray Mentor Petrela

OBJECT The aim of this study was to evaluate the impact of CCNU chemotherapy alone on low-grade glioma (LGG) growth dynamics. METHODS The authors measured the evolution of the mean tumor diameter (MTD) in adult patients with LGG before (n=28 patients) and after (n=38 patients) CCNU administration. RESULTS Natural (spontaneous) growth of LGG in the present study was 4.3 mm/year (range 2.1-6....

2014
Gideon M. Blumenthal Joell J. Gills Marc S. Ballas Wendy B. Bernstein Takefumi Komiya Roopa Dechowdhury Betsy Morrow Hyejeong Root Guinevere Chun Cynthia Helsabeck Seth M. Steinberg Jaclyn LoPiccolo Shigeru Kawabata Erin R. Gardner William D. Figg Phillip A. Dennis

Nelfinavir is an HIV protease inhibitor being repurposed as an anti-cancer agent in preclinical models and in small oncology trials, yet the MTD of nelfinavir has not been determined. Therefore, we conducted a Phase Ia study to establish the maximum tolerated dose (MTD) and dose limiting toxicities (DLT) of nelfinavir in subjects with advanced solid tumors. Adults with refractory cancers were g...

Journal: :Blood 2014
Shaji K Kumar William I Bensinger Todd M Zimmerman Craig B Reeder James R Berenson Deborah Berg Ai-Min Hui Neeraj Gupta Alessandra Di Bacco Jiang Yu Yaping Shou Ruben Niesvizky

Proteasome inhibition is an effective treatment strategy for multiple myeloma. With improving survival, attention is increasingly focusing on ease of administration and toxicity profile. Ixazomib is an investigational, orally bioavailable 20S proteasome inhibitor. Sixty patients with relapsed and/or refractory multiple myeloma were enrolled on this phase 1 trial to evaluate safety and tolerabil...

2014
M. E. Cazzaniga V. Torri F. Villa N. Giuntini F. Riva A. Zeppellini D. Cortinovis P. Bidoli

Background. Vinorelbine (VRB) and capecitabine (CAPE) are demonstrated to be active in pretreated metastatic breast cancer patients. Different studies have demonstrated that the metronomic treatment is active with an acceptable toxicity profile. We designed a Phases I-II study to define the MTD of oral metronomic, VRB, and CAPE. Patients and Methods. Phase I: fixed dose of CAPE was 500 mg thric...

2014
Kin-Joe Sham Leslie P. Kaelbling

The ability to distribute the proper number of weapons and planes depending on the available information and resources is crucial in a successful air strike campaign. Current algorithms for this problem domain such as Yost's hybrid approach and the Markov task decomposition (MTD) approach model the given problem using Markov decision processes, but only in minimal detail for computational feasi...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2000
K Itoh T Ohtsu H Wakita T Igarashi K Ishizawa Y Onozawa H Fujii H Minami Y Sasaki

BACKGROUND CHOP is accepted as the gold standard for first line chemotherapy of aggressive non-Hodgkin's lymphoma (NHL). A dose-escalation study of CHOP was conducted to determine the maximal tolerated dose (MTD) and toxicity profile of CHOP at three-week intervals with or without prophylactic recombinant human granulocyte colony-stimulating factor (rHuG-CSF) in patients with aggressive NHL. ...

Journal: :Acta medica Okayama 2008
Qiang Lin Xian-Shu Gao Xue-Ying Qiao Zhi-Guo Zhou Ping Zhang Kun Chen Yan-Nan Zhao Junichi Asaumi

We defined the maximum-tolerated dose (MTD) of chemoradiotherapy (cisplatin (CDDP) with 5-fluorouracil (5-FU) and concurrent chemoradiotherapy) for Chinese patients with esophageal cancer. Twenty-one previously untreated patients with primary esophageal cancer were entered into this study. Escalating doses of CDDP with 5-FU were administered in a modified Fibonacci sequence, with concurrent con...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
L R Duska R Penson J G Supko D M Finkelstein T Makastorsis J Gallagher K Borden A Goodman A F Fuller N Nikrui M V Seiden

A Phase I study of paclitaxel and doxorubicin administered as concurrent 96-h continuous i.v. infusion was performed to determine the maximum tolerated dose (MTD), principal toxicities, and pharmacokinetics of this combination in women with relapsed epithelial ovarian cancer. The paclitaxel dose was fixed at 100 mg/m2 (25 mg/m2/day for 4 days). The dose of doxorubicin was escalated from 30 mg/m...

Journal: :American journal of speech-language pathology 2015
Balaji Rangarathnam Gary H McCullough Hylan Pickett Richard I Zraick Ozlem Tulunay-Ugur Kimberly C McCullough

PURPOSE The purpose of this study was to investigate the utility of telepractice for delivering flow phonation exercises to persons with primary muscle tension dysphonia (MTD). METHOD Fourteen participants with a diagnosis of primary MTD participated, 7 on site and 7 at remote locations. Each participant received 12 treatment sessions across 6 weeks. Treatment consisted of flow phonation voic...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Whitney P Caron Katherine P Morgan Beth A Zamboni William C Zamboni

PURPOSE Nanoparticles or carrier-mediated agents have been designed to prolong drug circulation time, increase tumor delivery, and improve therapeutic index compared to their small-molecule counterparts. The starting dose for phase I studies of small molecules and nanoparticles anticancer agents is based on the toxicity profile of the most sensitive species (e.g., rat or canine), but the optima...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید